BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 15890988)

  • 1. Aggressive therapy with intravenous abciximab and intra-arterial rtPA and additional PTA/stenting improves clinical outcome in acute vertebrobasilar occlusion: combined local fibrinolysis and intravenous abciximab in acute vertebrobasilar stroke treatment (FAST): results of a multicenter study.
    Eckert B; Koch C; Thomalla G; Kucinski T; Grzyska U; Roether J; Alfke K; Jansen O; Zeumer H
    Stroke; 2005 Jun; 36(6):1160-5. PubMed ID: 15890988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute basilar artery occlusion treated with combined intravenous Abciximab and intra-arterial tissue plasminogen activator: report of 3 cases.
    Eckert B; Koch C; Thomalla G; Roether J; Zeumer H
    Stroke; 2002 May; 33(5):1424-7. PubMed ID: 11988626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of acute basilar artery occlusion: intraarterial thrombolysis alone vs bridging therapy.
    Nagel S; Schellinger PD; Hartmann M; Juettler E; Huttner HB; Ringleb P; Schwab S; Köhrmann M
    Stroke; 2009 Jan; 40(1):140-6. PubMed ID: 18927446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute vertebrobasilar occlusion: current treatment strategies.
    Eckert B
    Neurol Res; 2005; 27 Suppl 1():S36-41. PubMed ID: 16197822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abciximab as an adjunct to high-risk carotid or vertebrobasilar angioplasty: preliminary experience.
    Qureshi AI; Suri MF; Khan J; Fessler RD; Guterman LR; Hopkins LN
    Neurosurgery; 2000 Jun; 46(6):1316-24; discussion 1324-5. PubMed ID: 10834637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergent carotid stenting and intra-arterial abciximab in acute ischemic stroke due to tandem occlusion.
    Al-Mufti F; Amuluru K; Manning NW; Khan I; Peeling L; Gandhi CD; Prestigiacomo CJ; Pushchinska G; Fiorella D; Woo HH
    Br J Neurosurg; 2017 Oct; 31(5):573-579. PubMed ID: 28298139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined fibrinolysis using reduced-dose alteplase plus abciximab with immediate rescue angioplasty versus primary angioplasty with adjunct use of abciximab for the treatment of acute myocardial infarction: Asia-Pacific Acute Myocardial Infarction Trial (APAMIT) pilot study.
    Wong A; Mak KH; Chan C; Koh TH; Lau KW; Lim TT; Lim ST; Wong P; Sim LL; Lim YT; Tan HC; Lim YL
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):445-52. PubMed ID: 15274152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke: an open-label, dose-ranging, phase I study.
    Qureshi AI; Harris-Lane P; Kirmani JF; Janjua N; Divani AA; Mohammad YM; Suarez JI; Montgomery MO
    Neurosurgery; 2006 Oct; 59(4):789-96; discussion 796-7. PubMed ID: 16915119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment with intravenous abciximab and intraarterial tPA yields high recanalization rate in patients with acute basilar artery occlusion.
    Barlinn K; Becker U; Puetz V; Dzialowski I; Kunz A; Kepplinger J; von Kummer R; Gahn G
    J Neuroimaging; 2012 Apr; 22(2):167-71. PubMed ID: 21410816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined thrombolysis with abciximab and rtPA in patients with middle cerebral artery occlusion.
    Gahn G; Barlinn K; Dzialowski I; Puetz V; Kunz A; Hentschel H; Becker U
    Acta Neurol Scand; 2010 Jan; 121(1):63-6. PubMed ID: 20074286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-arterial thrombolysis for acute ischemic stroke: preliminary experience with platelet glycoprotein IIb/IIIa inhibitors as adjunctive therapy.
    Deshmukh VR; Fiorella DJ; Albuquerque FC; Frey J; Flaster M; Wallace RC; Spetzler RF; McDougall CG
    Neurosurgery; 2005; 56(1):46-54; discussion 54-5. PubMed ID: 15617585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous recanalization of acute internal carotid artery occlusions in patients with severe stroke.
    Dabitz R; Triebe S; Leppmeier U; Ochs G; Vorwerk D
    Cardiovasc Intervent Radiol; 2007; 30(1):34-41. PubMed ID: 17122887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local intraarterial urokinase thrombolysis of acute ischemic stroke with or without intravenous abciximab: a pilot study.
    Lee DH; Jo KD; Kim HG; Choi SJ; Jung SM; Ryu DS; Park MS
    J Vasc Interv Radiol; 2002 Aug; 13(8):769-74. PubMed ID: 12171979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke.
    Lee KY; Kim DI; Kim SH; Lee SI; Chung HW; Shim YW; Kim SM; Heo JH
    AJNR Am J Neuroradiol; 2004 Oct; 25(9):1470-5. PubMed ID: 15502123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-arterial thrombectomy versus standard intravenous thrombolysis in patients with anterior circulation stroke caused by intracranial arterial occlusions: a single-center experience.
    Sallustio F; Koch G; Di Legge S; Rossi C; Rizzato B; Napolitano S; Samà D; Arnò N; Giordano A; Tropepi D; Misaggi G; Diomedi M; Del Giudice C; Spinelli A; Fabiano S; Stefanini M; Konda D; Reale CA; Pampana E; Simonetti G; Stanzione P; Gandini R
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e323-31. PubMed ID: 23379980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endovascular therapy of acute vertebrobasilar occlusion: early treatment onset as the most important factor.
    Eckert B; Kucinski T; Pfeiffer G; Groden C; Zeumer H
    Cerebrovasc Dis; 2002; 14(1):42-50. PubMed ID: 12097850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-arterial tissue plasminogen activator and abciximab in patients with acute basilar artery occlusion.
    Chiti A; Gialdini G; Terni E; Giannini N; Gennaro M; Lazzarotti GA; Puglioli M; Orlandi G; Bonuccelli U
    Neurol Sci; 2013 Oct; 34(10):1871-3. PubMed ID: 23703399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
    Guagliumi G; Stone GW; Cox DA; Stuckey T; Tcheng JE; Turco M; Musumeci G; Griffin JJ; Lansky AJ; Mehran R; Grines CL; Garcia E
    Circulation; 2004 Sep; 110(12):1598-604. PubMed ID: 15353506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin generation and fibrinolytic activities among patients receiving reduced-dose alteplase plus abciximab or undergoing direct angioplasty plus abciximab for acute myocardial infarction.
    Mak KH; Lee LH; Wong A; Chan C; Koh TH; Lau KW; Lim YL
    Am J Cardiol; 2002 Apr; 89(8):930-6. PubMed ID: 11950430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reteplase monotherapy and reteplase/abciximab combination therapy in peripheral arterial occlusive disease: results from the RELAX trial.
    Ouriel K; Castaneda F; McNamara T; Swischuk J; Tepe G; Smith JJ; Clark J; Duda S
    J Vasc Interv Radiol; 2004 Mar; 15(3):229-38. PubMed ID: 15028807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.